Table 2.

Treatment and culprit lesions.

	Study Group (n = 44)	Control Group (n = 85)	p
Coronarography, n (%)	43 (97.73%)	82 (96.47%)	0.70
Optimal medical therapy, n (%)	1 (2.27%)	3 (3.53%)	0.70
Coronary artery bypass grafting qualified, n (%)	6 (13.64%)	3 (3.53%)	0.03
Percutaneous transluminal coronary angioplasty, n (%)	32 (72.73%)	73 (85.88%)	0.07
Reached TIMI 3, n (%)	30 (93.75%)	62 (84.93%)	0.15
Multivessel coronary artery disease, n (%)	16 (36.36%)	15 (17.65%)	0.02
Left main coronary artery, n (%)	1 (2.27%)	2 (2.35%)	0.73
Left anterior descending artery, n (%)	13 (29.55%)	25 (29.41%)	0.99
Diagonal branches, n (%)	3 (6.82%)	2 (2.35%)	0.21
Circumflex artery, n (%)	4 (9.09%)	7 (8.24%)	0.87
Obtuse marginal artery, n (%)	2 (4.55%)	3 (3.53%)	0.78
Right coronary artery, n (%)	7 (15.91%)	21 (24.71%)	0.25
Posterior descending artery, n (%)	0 (0%)	0 (0%)
Intermediate artery, n (%)	0 (0%)	1 (1.18%)	0.47
Bridge, n (%)	1 (2.27%)	1 (1.18%)	0.64
Stent length, mm	32.5 (23.25–57.5)	32 (21.5–48)	0.45
Staged revascularization *, n (%)	4 (9.09%)	1 (1.18%)	0.03

TIMI3: thrombolysis in myocardial infarction, * multiple interventions conducted during hospitalization.